azauridine has been researched along with azaribine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Groth, O | 1 |
| Alper, JC; Calabresi, P; McDonald, CJ; Rueckl, FS; Wiemann, MC | 1 |
| Drell, W; Welch, AD | 1 |
| Blanc, O; Slavik, M; Smith, KJ | 1 |
| Blanc, O; Slavik, J; Slavik, M; Smith, KJ | 1 |
| McDonald, CJ | 1 |
| Morton, MD; Mummert, MA; Riley, CM; Schowen, RL; Slavik, M; Vander Velde, DG; Zhou, J | 1 |
| Hong, J; Riley, CM; Schowen, RL; Shearer, EC; Zhou, J | 1 |
| Riley, CM; Schowen, RL; Zhou, J | 1 |
| Morrey, JD; Sidwell, RW; Smee, DF; Tseng, C | 1 |
| CALABRESI, P; CREASEY, WA; FINK, ME; HANDSCHUMACHER, RE; WELCH, AD | 1 |
| CALABRESI, P; CREASEY, WA; FINK, ME; HANDSCHUMACHER, RE | 1 |
| CALABRESI, P; TURNER, RW | 1 |
| Almazan, F; Ávila-Pérez, G; de la Torre, JC; Martinez-Sobrido, L; Morales Vasquez, D; Nogales, A; Park, JG | 1 |
2 review(s) available for azauridine and azaribine
| Article | Year |
|---|---|
Azaribine-homocystinemia-thrombosis in historical perspective.
Topics: Animals; Antimetabolites; Azauridine; Homocysteine; Humans; Thrombosis; Vitamin B 6 Deficiency | 1989 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; Hydroxyurea; Mercaptopurine; Mustard Compounds; Mycophenolic Acid; Psoriasis | 1981 |
1 trial(s) available for azauridine and azaribine
| Article | Year |
|---|---|
Rationally designed combination chemotherapy for the treatment of patients with recalcitrant psoriasis.
Topics: Adult; Aged; Azauridine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Time Factors | 1985 |
13 other study(ies) available for azauridine and azaribine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Cytostatic therapy of psoriasis].
Topics: Antineoplastic Agents; Azauridine; Humans; Hydroxyurea; Methotrexate; Psoriasis | 1979 |
Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine.
Topics: Animals; Azauridine; Female; Homocystine; Male; Pyridoxal Phosphate; Pyridoxine; Rabbits; Time Factors | 1982 |
6-azauridine triacetate induced hyper beta-alaninemia and its decrease by administration of pyridoxine.
Topics: Alanine; Animals; Azauridine; beta-Alanine; Drug Interactions; Female; Male; Pyridoxine; Rabbits | 1983 |
Hydrolysis of the prodrug, 2',3',5'-triacetyl-6-azauridine.
Topics: Azauridine; Drug Stability; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Kinetics; Models, Chemical; Molecular Structure; Prodrugs; Solutions; Temperature; Thermodynamics; Water | 1995 |
Automated analytical systems for drug development studies. V. A system for enzyme kinetic studies.
Topics: Animals; Azauridine; Chromatography, High Pressure Liquid; Dipeptides; Drug Design; Esterases; Hydrolysis; Liver; Microdialysis; Pepsin A; Reproducibility of Results; Swine | 1996 |
In vitro metabolism studies of the prodrug, 2',3',5'-triacetyl-6-azauridine, utilizing an automated analytical system.
Topics: Algorithms; Animals; Antifungal Agents; Azauridine; Buffers; Esterases; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Liver; Microdialysis; Prodrugs; Temperature | 2001 |
Identification of active antiviral compounds against a New York isolate of West Nile virus.
Topics: Amides; Animals; Antiviral Agents; Azauridine; Chlorocebus aethiops; Cytidine; Cytopathogenic Effect, Viral; Enzyme Inhibitors; Inhibitory Concentration 50; Mycophenolic Acid; New York; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Thiouridine; Vero Cells; Virus Replication; West Nile virus | 2002 |
Pharmacological and clinical studies with triacetyl 6-azauridine.
Topics: Antineoplastic Agents; Azauridine; Biomedical Research; Nucleosides; Nucleotides | 1962 |
Clinical and pharmacological studies with 2',3',5'-triacetyl-6-azauridine.
Topics: Azauridine; Neoplasms; Nucleosides; Research | 1963 |
THE EFFECT OF TRIACETYL AZAURIDINE ON PSORIASIS.
Topics: Anemia; Azauridine; Drug Therapy; Hematopoietic System; Humans; Mycosis Fungoides; Nucleosides; Pathology; Proteins; Psoriasis; Pyrimidines; Toxicology | 1964 |
Identification of Inhibitors of ZIKV Replication.
Topics: A549 Cells; Animals; Antiviral Agents; Apoptosis; Azauridine; Biphenyl Compounds; Carbamates; Cell Survival; Chlorocebus aethiops; Drug Repositioning; Guillain-Barre Syndrome; Humans; Microcephaly; Phenylurea Compounds; Uganda; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2020 |